Web Analytics

Investor Profile

ARCH Venture Partners

ARCH Venture Partners United States - Chicago, IL
INVESTOR

1 Disclosed Funding Rounds $261,000,000
17 Participating Investments




Early stage venture firm focused on life science discoveries to prevent, detect and cure disease.

Invested In

Company Date Round Raised
  Treeline Biosciences October, 18 ,2022 Series A $261,000,000
  Neumora October, 17 ,2022 Series B $112,000,000
  Happy Health August, 24 ,2022 Series A $60,000,000
  Homeward August, 03 ,2022 Series B $50,000,000
  Paradigm January, 30 ,2023 Series A $200,000,000
  Rapport Therapeutics March, 08 ,2023 Series A $100,000,000
  Volastra Therapeutics March, 08 ,2023 Series A $60,000,000
  Colossal Biosciences March, 09 ,2022 Series A $60,000,000
  Orbital Therapeutics April, 27 ,2023 Series A $270,000,000
  Boundless Bio May, 17 ,2023 Series C $100,000,000
  OncoResponse May, 19 ,2023 Unknown $14,000,000
  Myeloid Therapeutics May, 19 ,2023 Unknown $73,000,000
  Mozart Therapeutics, Inc June, 08 ,2023 Series A $25,000,000
  Lightcast Discovery August, 18 ,2023 Series B $49,000,000
  Generate:Biomedicines September, 18 ,2023 Series C $273,000,000
  Magnet Biomedicine September, 20 ,2023 Unknown $50,000,000
  AIRNA September, 20 ,2023 Unknown $30,000,000